Trial Information

Summary: A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects with Moderately Active Crohn’s Disease.

Screening period of 14 days:

• Informed Consent
• Physical examination, blood tests and assessment of Crohn’s
• Questionnaires

Inclusion Criteria:

• 18 years or older
• With diagnosis of Crohn’s for at least 6 months, that has been appropriately documented and confirmed by radiology, endoscopes or surgical pathology
• Must be willing to adhere to study visit schedule and self-injection of study medication
• Body weight between 88 & 220 pounds

Exclusion Criteria:

• Pregnant or lactating females
• Current ileostomy or colostomy or extensive fistula’s
• History of ulcerative colitis
• Chronic liver disease

If you would like to learn more about participating in this study, please send an e-mail message using the form below.